This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: University of Missouri, Rutgers, The State University of New Jersey. Active years: 2016-2026.
Company Filing History:
3 out of 894 
1 out of 1,492 
Years Active: 2016-2026
Title: Kamlendra Singh: Innovator in HIV Research
Introduction
Kamlendra Singh is a notable inventor based in Columbia, MO (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic agents.
Latest Patents
Kamlendra Singh holds 3 patents, with his latest inventions focusing on peptide inhibitors for the inhibition of HIV capsid. His work includes the development of aryl and heteroaryl amides for use as anti-proliferative, anti-thrombotic, and anti-viral agents. The patents disclose certain compounds of formula I, including their pharmaceutically acceptable salts. Additionally, he has outlined pharmaceutical compositions comprising these compounds, processes for their preparation, and therapeutic methods utilizing them.
Career Highlights
Throughout his career, Kamlendra Singh has worked with prestigious institutions such as the University of Missouri and Rutgers, the State University of New Jersey. His research has been pivotal in advancing the understanding and treatment of viral infections.
Collaborations
Kamlendra has collaborated with esteemed colleagues, including Thomas Walter Comollo and Stefan G Sarafianos, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Kamlendra Singh's work exemplifies the spirit of innovation in the fight against HIV and other viral diseases. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.